Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025)
Fennec Pharmaceuticals posted quarterly Amortizatization of Intangibles of -$12000.0 for Q4 2025, down 101.63% year-on-year from $736000.0 in Q4 2024, and down 146.15% on a QoQ basis from $26000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 5 years of Amortizatization of Intangibles data on file, last reported at -$12000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 101.63% year-over-year to -$12000.0; the trailing twelve-month figure through Dec 2025 stood at $65000.0 (down 91.88% YoY), and the FY2025 full-year result was $65000.0, down 91.88% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at -$12000.0, down from $26000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $736000.0 in Q4 2024 and bottomed at -$685000.0 in Q3 2024.
- The 5-year median for Amortizatization of Intangibles is $15000.0 (2022), against an average of $59312.5.
- Peak annual rise in Amortizatization of Intangibles reached 4806.67% in 2024, while the deepest fall reached 3705.26% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1000.0 in 2021, then soared by 1400.0% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then jumped by 4806.67% to $736000.0 in 2024, then sank by 101.63% to -$12000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at -$12000.0 (Q4 2025), $26000.0 (Q3 2025), and $38000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 736,000.00 |
| Dec 31, 2024 | 736,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 723,000.00 |
| Mar 31, 2024 | 723,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |